Literature DB >> 14965230

Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention.

F A Crocenzi1, A D Mottino, M G Roma.   

Abstract

Bile formation is an osmotic process driven by the vectorial transport of actively transferred biliary components across the basolateral (sinusoidal) and apical (canalicular) hepatocyte membranes, the latter being the rate-limiting step of the overall blood-to-bile transfer. The ATP-binding cassette (ABC) superfamily of membrane transporters comprises novel ATP-dependent carriers that mediate canalicular transfer of several endogenous and exogenous substrates, and therefore play a key role in bile formation. Gene expression, as well as the balance between vesicular targeting and internalization of these transporters to/from the canalicular membrane are highly regulated processes. This balance is affected in several models of hepatocellular cholestasis, and these alterations may either initiate or perpetuate the cholestatic manifestations. This review describes the regulation of the normal activity of hepatocellular ABC transporters, focusing on the involvement of transcription factors and signaling pathways in the regulation of carrier synthesis, dynamic localization and phosphorylation status. Its alteration in different experimental models of cholestasis, such as those induced by estrogens, lipopolysaccharide (endotoxin), monohydroxylated bile salts and oxidative stress, is also reviewed. Finally, several experimental therapeutic approaches based upon the administration of compounds known/thought to induce carrier synthesis (e.g., protein synthesis inducers), to counteract etiological factors responsible for the cholestatic disease (e.g., corticoids in lipopolysaccharide-induced cholestasis) or to stimulate exocytic insertion of canalicular transporters (e.g., cAMP, silymarin or tauroursodeoxycholate) are described with respect to their ability to prevent cholestatic alterations; the role of signaling molecules as putative downstream mediators of their effects are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965230     DOI: 10.2174/0929867043455918

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.

Authors:  Daniel Y Hung; Gerhard A Siebert; Ping Chang; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 2.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency.

Authors:  Lu Wang; Jingbo Wang; Weile Cai; Yongquan Shi; Xinmin Zhou; Guanya Guo; Changcun Guo; Xiaofeng Huang; Zheyi Han; Shuai Zhang; Shuoyi Ma; Xia Zhou; Daiming Fan; M Eric Gershwin; Ying Han
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 4.  Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents.

Authors:  Aldo-D Mottino; Viviana-A Catania
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

5.  Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat.

Authors:  Fernando A Crocenzi; Enrique J Sánchez Pozzi; María Laura Ruiz; Andrés E Zucchetti; Marcelo G Roma; Aldo D Mottino; Mary Vore
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

6.  Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.

Authors:  Ahmad Sharanek; Pamela Bachour-El Azzi; Houssein Al-Attrache; Camille C Savary; Lydie Humbert; Dominique Rainteau; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

Review 7.  Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives.

Authors:  Peter F Surai
Journal:  Antioxidants (Basel)       Date:  2015-03-20

8.  Sequential activation of classic PKC and estrogen receptor α is involved in estradiol 17ß-D-glucuronide-induced cholestasis.

Authors:  Ismael R Barosso; Andrés E Zucchetti; Andrea C Boaglio; M Cecilia Larocca; Diego R Taborda; Marcelo G Luquita; Marcelo G Roma; Fernando A Crocenzi; Enrique J Sánchez Pozzi
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.